Discover Great Companies Discover Great Clients

Company Overview

Development Stage

About the Company

CASI is a biopharmaceutical company listed on the NASDAQ in the United States, dedicated to providing patients in China with the most advanced treatment options in the field of hematological malignancies. Our headquarters are located in Rockville, Maryland, USA, and we have wholly-owned subsidiaries as well as production and R&D centers in Beijing and Wuxi, Jiangsu Province. Our goal is to become a leading enterprise in China and globally in the field of hematological tumors. Currently, our products and R&D pipeline cover multiple myeloma, B-cell non-Hodgkin lymphoma, acute lymphoblastic leukemia, and other disease areas. We have established connections with major global research institutions focusing on blood diseases, striving to commercially translate breakthrough scientific achievements as quickly as possible. In the future, CASI will continue to increase investment in R&D and the introduction of new drugs, extend patients' lives, and become a partner to physicians.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (24 open positions)

Manage
Note: How fast is hiring at CASI Pharmaceuticals (China) Co., Ltd. growing? 2026: 29 openings (up 123%), 2025: 13 openings (up 117%), 2024: 6 openings (down 14%), 2023: 7 openings (down 73%), 2022: 26 openings (down 45%), 2021: 47 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
N/A
Growth Rate
Master's Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at CASI Pharmaceuticals (China) Co., Ltd. growing? Master's recruitment over the years: 2026: 5 openings (up 123%), 2023: 1 openings (down 73%), 2022: 3 openings (down 45%), 2021: 2 openings.

Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Doctoral Hiring by Year: 2022 — same as 2021
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at CASI Pharmaceuticals (China) Co., Ltd. growing? Doctorate recruitment over the years: 2022: 1 openings (down 45%), 2021: 1 openings.

— What Are the Salaries Like? (29 records)

Manage
salary range: 2K - 50K, 48.2% of roles pay ¥10-20K
Note: salary statistics are based on 29 salary records from the past year and depend on the job sample. For reference only.
How is the salary at CASI Pharmaceuticals (China) Co., Ltd.?48.2% of positions earn 10-20K, Fresh graduate salary: ¥5.8K。销售类 average salary ¥22.5K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at CASI Pharmaceuticals (China) Co., Ltd.? We provide: 信息,医药代表,财务,运营,会计,医学事务总监,销售,ai工程师,it经理,qa,qc,ra,vp助理,临床,分析,医学事务经理,医学顾问,实习生,机器学习,生产工. Click to view detailed salary analysis by job.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 销售类
    37.9% of total 37.9%
  • 医疗卫生/美容保健类
    20.7% of total 20.7%
  • 计算机/网络/技术类
    20.7% of total 20.7%
  • 经营管理类
    17.2% of total 17.2%

Education

  • 本科
    58.6% of total 58.6%
  • 大专
    20.7% of total 20.7%
  • 硕士
    17.2% of total 17.2%
  • 不限
    3.4% of total 3.4%

Experience

  • 1-3年
    34.5% of total 34.5%
  • 3-5年
    27.6% of total 27.6%
  • 5-10年
    17.2% of total 17.2%
  • 不限
    13.8% of total 13.8%
View Detailed Analysis

What does CASI Pharmaceuticals (China) Co., Ltd. require? Who is CASI Pharmaceuticals (China) Co., Ltd. hiring? recruitment: 销售类占比最多占37.9%,其次是医疗卫生/美容保健类占20.7%. What education can get in at ? 本科占比最多占58.6%,其次是大专占20.7%. High education required at ? 硕士占17.2%. Work experience required at ? 1-3年占比最多占34.5%,其次是3-5年占27.6%. Where are the job locations at ? 北京占比最多占58.6%,其次是无锡占13.8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 800万(美元)
Legal Representative: 何为无(HE WEIWU)
Date Established:
Credit Code: 91110105599603317U
Registered Address: 北京市朝阳区建国路81号17层17办公1T01内01、02室

Partners & Suppliers

药明生物为基石药业提供抗体药物生产等CMO服务。 Source
供应商 CRO/CMO服务
华润医药为基石药业提供药品分销及物流服务。 Source
合作客户 药品商业化合作
康龙化成为基石药业提供药物发现、临床前安全评价等CRO服务。 Source
供应商 CRO/CMO服务
国药控股为基石药业提供药物分销及供应链服务。 Source
合作客户 药品商业化合作
礼来获得基石药业RET抑制剂普拉替尼在中国大陆的独家商业化权利。 Source
合作客户 药品商业化合作

People who follow this company also follow

Competitors (Similar Companies)

“A domestic first-class, internationally renowned biotechnology enterpr”
“Large-scale pharmaceutical distribution enterprise”
研究院/研究所 生物信息 生物信息学 蛋白质组学
药物研发 生物医药 仿制药 化学合成药
生命科学研究 干细胞 基因工程 抗衰老
医药 药物研发 生物制药 临床前研究
“A technology-driven international pharmaceutical enterprise”
医药 药物研发 生物医药 新药研发
“Time-honored brand in the traditional Chinese medicine industry”
彩超 心电图室 社区卫生服务 康复
医学科技/技术 生产 耗材 研发
医药 生物制品 生物医药 生物制药
诊断试剂 生物医药 疫苗 生物科技/生物工程
研究院/研究所 医药 抗体 生物医药
制药/药业 医药 生物医药 新药研发

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates